Keywords: Salix Pharma, NDA, Crofelemer, Napo Pharma, Glenmark, Arbitration

Salix files Crofelemer NDA as spat with Napo moves to Glenmark

Article | 15 December 2011

Print This

USA-based Salix Pharmaceuticals (Nasdaq) said yesterday that it has submitted a New Drug Application to the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in